Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
The New England Journal of Medicine
|
May 16, 1991
Clomipramine in the treatment of self-mutilating behaviors
J F Lipinski
The American Journal of Psychiatry
|
November 1, 1986
Alprazolam-neuroleptic combination in schizophrenia
J F Lipinski, B M Cohen
Life Sciences
|
December 29, 1986
In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action
B M Cohen, J F Lipinski
The New England Journal of Medicine
|
August 23, 1973
Risks vs. benefits of antipsychotic drugs
R J Baldessarini, J F Lipinski
Annals of Internal Medicine
|
October 1, 1975
Lithium salts: 1970-1975
R J Baldessarini, J F Lipinski
The New England Journal of Medicine
|
September 3, 1981
Risks of antipsychotic drugs overemphasized
R J Baldessarini, J F Lipinski
Archives of General Psychiatry
|
July 1, 1978
Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research
H G Pope, J F Lipinski
The American Journal of Psychiatry
|
July 1, 1982
Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients
J F Lipinski, H G Pope
Psychosomatics
|
January 1, 1986
Treatment of acute psychosis with non-neuroleptic agents
B M Cohen, J F Lipinski
Comprehensive Psychiatry
|
July 1, 1994
Do "flashbacks" represent obsessional imagery?
J F Lipinski, H G Pope
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
The New England Journal of Medicine
|
May 16, 1991
Clomipramine in the treatment of self-mutilating behaviors
J F Lipinski
The American Journal of Psychiatry
|
November 1, 1986
Alprazolam-neuroleptic combination in schizophrenia
J F Lipinski, B M Cohen
Life Sciences
|
December 29, 1986
In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action
B M Cohen, J F Lipinski
The New England Journal of Medicine
|
August 23, 1973
Risks vs. benefits of antipsychotic drugs
R J Baldessarini, J F Lipinski
Annals of Internal Medicine
|
October 1, 1975
Lithium salts: 1970-1975
R J Baldessarini, J F Lipinski
The New England Journal of Medicine
|
September 3, 1981
Risks of antipsychotic drugs overemphasized
R J Baldessarini, J F Lipinski
Archives of General Psychiatry
|
July 1, 1978
Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research
H G Pope, J F Lipinski
The American Journal of Psychiatry
|
July 1, 1982
Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients
J F Lipinski, H G Pope
Psychosomatics
|
January 1, 1986
Treatment of acute psychosis with non-neuroleptic agents
B M Cohen, J F Lipinski
Comprehensive Psychiatry
|
July 1, 1994
Do "flashbacks" represent obsessional imagery?
J F Lipinski, H G Pope
Page
of 6